Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer.

Conclusions: Our results suggest that inactivating HRR-related gene mutations are predictive of response to oxaliplatin-based chemotherapy in patients with PDAC.
PMID: 29731985 [PubMed]

Source: Oncotarget - May 9, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research